Numerous Mendelian cardiac and vascular diseases associated with AF are now known to result from inherited perturbations of TGF-β signaling and it is certainly conceivable that subtle variation in these same pathways during PV angiogenesis and atrial patterning may contribute to abnormal myocyte networks that sustain AF. This evidence concerns the gene TGFB1 and atrial fibrillation.